Adaptimmune Therapeutics News

Adaptimmune Therapeutics | 8-K: Current report

Sep 23 16:19 ET

Adaptimmune Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 07:26 ET

Adaptimmune Therapeutics | 8-K: Current report

Aug 12 07:10 ET

Adaptimmune Therapeutics | 8-K: Current report

Aug 2 07:04 ET

Adaptimmune Therapeutics | 8-K: Current report

Jul 16 16:33 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali

Jul 1 17:14 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MOTT DAVID M

Jul 1 17:09 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Menzel Garry E

Jul 1 17:09 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Alleva Lawrence M

Jul 1 17:05 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Furey John

Jul 1 17:05 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hegde Priti

Jul 1 17:05 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hege Kristen

Jul 1 17:05 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Allen Andrew R

Jul 1 17:04 ET

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Piccina Cintia

Jun 18 17:06 ET

Adaptimmune Therapeutics | 8-K: Current report

Jun 11 16:22 ET

Adaptimmune Therapeutics | 8-K: Current report

May 30 16:15 ET

Adaptimmune Therapeutics | 10-Q: Q1 2024 Earnings Report

May 15 22:23 ET

Adaptimmune Therapeutics | 8-K: Current report

May 15 07:45 ET

Adaptimmune Therapeutics | 8-K: Current report

May 15 07:20 ET

Adaptimmune Therapeutics | 8-K: Current report

May 14 07:39 ET